US Male Breast Cancer Market: The Critical Role of Precision...

added blog Health

2025-12-08 10:06:35 -

US Male Breast Cancer Market: The Critical Role of Precision Oncology in Targeting Rare Subtypes.

Identifying and Addressing the Small, Highly Aggressive HER2-Positive Subtype While the majority of male breast cancers are Estrogen Receptor-Positive (ER+), a small but clinically significant number are Human Epidermal growth factor Receptor 2-Positive (HER2+), typically accounting for less than 5% of cases. This subtype is known for its aggressive biology and historically poor prognosis. The...

0 Comments 0 Shares 111 Views 0 Reviews